Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

Share Price is delayed by 15 minutes
Get Live Data
115.00    3.50 (3.14%)
Bid:
112.00
Ask:
118.00
Spread: 6.00 (5.357%)
Market Cap: £69.19m
IGP Live PriceLast checked at - London Stock Exchange

Intraday Intercede Share Chart

Amendment to LTIP

23 Feb 2021 07:00

RNS Number : 9555P
Intercede Group PLC
23 February 2021
 

23 February 2021

Intercede Group plc

 

("Intercede" or the "Company")

 

Amendment to LTIP

 

 

Following the successful early retirement of the Company's Loan Notes announced on 4 and 16 February 2021, Intercede's Remuneration Committee has determined the following amendments to the existing Intercede Group plc Long Term Incentive Plan (the "LTIP"), as previously announced on 22 October 2018:

 

Revised Performance Criteria

 

· Tranche 1 has been achieved (previously subject to the achievement of an average share price of 69p for a period of 30 consecutive trading days up to and ending 19 October 2021); and

 

· Tranches 2 and 3 will now be triggered subject to the achievement of an average share price of 69p and 119p respectively for a period of 30 consecutive trading days up to and ending 19 October 2021 (previously 119p and 169p respectively).

 

Dependent on the Performance Criteria above being achieved, the number of Options that will vest and become exercisable at an exercise price of 27p (being the closing mid-market price of an Ordinary Share on 18 October 2018, when the LTIP was implemented) from 19 October 2021 to 18 October 2028 is as follows:

Director

Tranche 1

Tranche 2

Tranche 3

Klaas van der Leest

500,000 Options

250,000 Options

250,000 Options

Andrew Walker

350,000 Options

150,000 Options

150,000 Options

 

Chuck Pol, Remuneration Committee Chairman, said:

 

"The LTIP was put in place following the appointment of Klaas van der Leest on 10 April 2018 to incentivise the management team to deliver a performance that would enable the Company to address its Convertible Loan Notes totalling £5.0m when they matured on 29 December 2021.

 

The successful execution of a turnaround plan has enabled Intercede to return to profit and to increase gross cash balances from £2.3m as at 31 March 2018 to £8.1m as at 30 September 2020 during a time when trading conditions have not been favourable.

 

The Remuneration Committee considers the early retirement of the Loan Notes to represent a significant achievement, particularly given that 12 out of 13 loan note holders elected to convert their Loan Notes into shares."

 

 

 

ENQUIRIES

 

Intercede Group plc

Tel. +44 (0)1455 558111

Klaas van der Leest, Chief Executive

Andrew Walker, Finance Director

finnCap

Tel. + 44 (0)20 7220 0500

Stuart Andrews / Simon Hicks, Corporate Finance

Tim Redfern / Charlotte Sutcliffe, ECM

 

About Intercede

 

Intercede is a cybersecurity company specialising in digital identities, credential management and secure mobility.

 

Headquartered in the UK, with offices in the US, we believe in a connected world in which people and technology are free to exchange information securely, and complex insecure passwords become a thing of the past.

 

Our vision is to make the highest levels of cybersecurity available to all organisations, solving complexity issues by simplifying the management of digital credentials, securely and at scale.

 

We have been delivering trusted solutions to high profile customers for over 20 years. Our team of experts has deployed millions of identities to governments, most of the largest aerospace and defence corporations, and major financial services and healthcare organizations, as well as leading telecommunications, cloud services and information technology firms, providing industry-leading employee and customer credential management systems.

 

For more information visit: www.intercede.com

 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBRGDDISDDGBD
Date   Source Headline
15th Mar 20121:02 pmRNSIssue of Equity
17th Feb 20127:00 amRNSDirector/PDMR Shareholding
16th Feb 20127:00 amRNSTrading Update
12th Dec 20117:00 amRNSUS Expansion
7th Dec 201112:00 pmRNSSales Alliance
1st Dec 20117:00 amRNSInterim Results
14th Nov 20117:00 amRNSNew Partnership
4th Oct 20117:00 amRNSNew Contract Win
21st Sep 20112:55 pmRNSResult of AGM
21st Sep 20117:00 amRNSAGM Statement and Update
17th Aug 20117:00 amRNSDirector/PDMR Share Option Awards
4th Aug 20113:39 pmRNSDirector/PDMR Shareholding
7th Jun 20117:00 amRNSFinal Results
7th Apr 20117:00 amRNSTrading Update
18th Jan 20119:32 amRNSDirector/PDMR Shareholding
6th Dec 20107:00 amRNSTransaction in Own Shares
30th Nov 201011:02 amRNSAdditional Listing and Director dealing
29th Nov 20107:00 amRNSIntercede Group Interim Results
4th Nov 20107:00 amRNSReduction of Share Capital
7th Oct 20107:54 amRNSPositive Trading Update
30th Sep 20107:00 amRNSNew Contract Win
24th Sep 20102:00 pmRNSResult of AGM
22nd Sep 20107:00 amRNSNew Contract Win
7th Sep 20107:00 amRNSPositive Trading Update
15th Jul 20107:00 amRNSLaunch of latest version of MyID PIV
6th Jul 20103:48 pmRNSChange of name of adviser
10th Jun 20107:00 amRNSFinal Results
8th Apr 20107:00 amRNSTrading Update
25th Mar 201012:30 pmRNSSettlement of Patent Dispute
2nd Mar 20107:00 amRNSDirector/PDMR Shareholding
1st Mar 20102:00 pmRNSMajor Subcontract with Thales
1st Feb 20107:00 amRNSNew Aerospace and Defence Contract Win
18th Jan 20104:36 pmRNSDirector/PDMR Shareholding
8th Dec 20097:00 amRNSInterim Results
11th Nov 20097:00 amRNSNew Middle East Contract Win
26th Oct 20097:00 amRNSRelease of latest Version of MyID / New Customers
12th Oct 20097:00 amRNSNational Identity Project in Kuwait
7th Oct 20097:00 amRNSTrading Update
17th Sep 20093:57 pmRNSResult of AGM
29th Jun 20095:11 pmRNSTotal Voting Rights
10th Jun 20097:00 amRNSFinal Results
8th Jun 20095:28 pmRNSDirector/PDMR Shareholding
1st Jun 20097:00 amRNSConversion of Loan Notes
14th May 20097:00 amRNSNew Contract with European Bank
30th Apr 20097:00 amRNSNew European Government Contract
2nd Apr 20097:00 amRNSTrading Update
1st Apr 20097:00 amRNSChange of Adviser
31st Mar 20097:00 amRNSTotal Voting Rights
30th Mar 20097:00 amRNSMaritime Credentialing Program Update
10th Mar 200910:21 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.